Forrest H. Anthony, M.D., Ph.D., has more than 25 years’ experience in the biopharmaceutical industry. He conducts early engagement with innovative immuno-oncology companies, offering QuintilesIMS resources and insights for global oncology clinical development projects.
Previously a biotech entrepreneur, he founded several companies, serving as CEO, CMO, or VP of oncology clinical development. He was the CEO and founder of Quality Biotech Inc, a contract biosafety testing lab for biotherapeutics, and created affiliated companies in Glasgow and Belgium. He was on the founding Executive Committee of the Biotechnology Industry Organization (BIO) trade association Board after serving as President (1991-92) of the Association of Biotechnology Companies (ABC) one of the two precursor trade associations that merged to form BIO. He started his career as a researcher at J & J and Rorer Group (now Sanofi).
Forrest holds a Bachelor’s degree in Biology and a Master of Medical Science from Dartmouth College and Dartmouth Medical School, an M.D. from Oregon Health Sciences University, and a Ph.D. in Biomedical Engineering from University of Virginia. He completed a Residency in Internal Medicine in Oregon, and is a licensed MD.